Edit |   |
---|---|
Antigenic Specificity | CGRP, Human (Eptinezumab biosimilar) |
Clone | Eptinezumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IHC, IF, IP, FCM, Inhib |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CGRP Recombinant Antibody (Eptinezumab). Eptinezumab, sold under the brand name Vyepti, is a medication for the preventive treatment of migraine in adults. It is a monoclonal antibody that targets calcitonin gene-related peptides (CGRP) alpha and beta. It is administered by intravenous infusion every three months. Eptinezumab-jjmr was approved for use in the United States in February 2020. |
Immunogen | n/a |
Other Names | Anti-CGRP Recombinant Antibody, Research Grade Eptinezumab, Anti-Human CGRP Recombinant Antibody(Eptinezumab), ALD-403, Antibody Drug Analogues, Monoclonal Antibody, YR1428, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1644539-04-7 |
Catalog # | YR1428 |
Price | please inquire |
Order / More Info | CGRP, Human (Eptinezumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |